Otolaryngology Doctors in Rutherford, NJ Accepting Medicare

4 Otolaryngology doctors found. Showing 1 - 4

Dr. Michael J Katz, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 47 Orient Way, Lower Level, Rutherford, NJ 07070 Phone: 201-935-5508    Fax: 201-935-4166

Dr. Edward J Sarti, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 47 Orient Way, Lower Level, Rutherford, NJ 07070 Phone: 201-935-5508    Fax: 201-935-4166

Dr. Sherif A Hassan, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 47 Orient Way, Lower Level, Rutherford, NJ 07070 Phone: 201-935-5508    Fax: 201-935-4166

Dr. Michael Zozzaro, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 47 Orient Way, Unit 28, Rutherford, NJ 07070 Phone: 201-935-5508    Fax: 201-465-6088

News Archive

Measles infection in early childhood could contribute to later COPD

In a new Respirology study, having measles—a highly contagious respiratory infection—during early childhood was linked with an increased risk of developing chronic obstructive pulmonary disease in middle age, but only in adults with asthma and a considerable history of smoking.

AAN awards Cedars-Sinai researcher 2010 Sheila Essey Award for ALS research

The American Academy of Neurology (AAN) is awarding the 2010 Sheila Essey Award-An Award for ALS Research to Clive Svendsen, PhD, with the Cedars-Sinai Regenerative Medicine Institute in Los Angeles, CA. Svendsen will receive the award during the AAN's 62nd Annual Meeting in Toronto, held April 10 through April 17, 2010.

Systems characterization of cell surface receptors

Cells communicate with their environment through molecules on their surface known as receptors.

Valentx raises funds to develop less-invasive treatment for morbid obesity

ValenTx, Inc., announced today the closing of a $22 million Series B Preferred Stock financing. The round was led by SV Life Sciences and joined by Covidien Ventures, as well as all the Company's existing venture capital investors: Sapient Capital, EDF Ventures, Kaiser Permanente Ventures, Affinity Capital Partners, and TGap Ventures.

Read more Medical News

› Verified 1 days ago